133 related articles for article (PubMed ID: 1606790)
1. Absorption of high dose furosemide (frusemide) in congestive heart failure.
Van Meyel JJ; Gerlag PG; Smits P; Russel FG; Tan Y; Van Ginneken CA; Gribnau FW
Clin Pharmacokinet; 1992 Apr; 22(4):308-18. PubMed ID: 1606790
[TBL] [Abstract][Full Text] [Related]
2. Furosemide absorption altered in decompensated congestive heart failure.
Vasko MR; Cartwright DB; Knochel JP; Nixon JV; Brater DC
Ann Intern Med; 1985 Mar; 102(3):314-8. PubMed ID: 3970471
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of furosemide in patients with congestive heart failure.
Greither A; Goldman S; Edelen JS; Benet LZ; Cohn K
Pharmacology; 1979; 19(3):121-31. PubMed ID: 523503
[TBL] [Abstract][Full Text] [Related]
4. Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: long-term effects.
Licata G; Di Pasquale P; Parrinello G; Cardinale A; Scandurra A; Follone G; Argano C; Tuttolomondo A; Paterna S
Am Heart J; 2003 Mar; 145(3):459-66. PubMed ID: 12660669
[TBL] [Abstract][Full Text] [Related]
5. Steady state absorption kinetics and pharmacodynamics of furosemide in congestive heart failure.
Chaturvedi PR; O'Donnell JP; Nicholas JM; Shoenthal DR; Waters DH; Gwilt PR
Int J Clin Pharmacol Ther Toxicol; 1987 Mar; 25(3):123-8. PubMed ID: 3557737
[TBL] [Abstract][Full Text] [Related]
6. Effect of high-dose furosemide in refractory congestive heart failure.
Marangoni E; Oddone A; Surian M; Panciroli C; Galloni G; Masa A; Caizzi V; Belletti S; Cominesi WR; Orlandi M
Angiology; 1990 Oct; 41(10):862-8. PubMed ID: 2221464
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic changes in patients with oedema.
Vrhovac B; Sarapa N; Bakran I; Huic M; Macolic-Sarinic V; Francetic I; Wolf-Coporda A; Plavsic F
Clin Pharmacokinet; 1995 May; 28(5):405-18. PubMed ID: 7614778
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure.
Vargo DL; Kramer WG; Black PK; Smith WB; Serpas T; Brater DC
Clin Pharmacol Ther; 1995 Jun; 57(6):601-9. PubMed ID: 7781259
[TBL] [Abstract][Full Text] [Related]
9. In chronic heart failure with marked fluid retention, the i.v. high doses of loop diuretic are a predictor of aggravated renal dysfunction, especially in the set of heart failure with normal or only mildly impaired left ventricular systolic function.
De Vecchis R; Ciccarelli A; Ariano C; Cioppa C; Giasi A; Pucciarelli A; Cantatrione S
Minerva Cardioangiol; 2011 Dec; 59(6):543-54. PubMed ID: 21330961
[TBL] [Abstract][Full Text] [Related]
10. Absorption and disposition of furosemide in congestive heart failure.
Brater DC; Seiwell R; Anderson S; Burdette A; Dehmer GJ; Chennavasin P
Kidney Int; 1982 Aug; 22(2):171-6. PubMed ID: 7132061
[TBL] [Abstract][Full Text] [Related]
11. Increased toxicity of high-dose furosemide versus low-dose dopamine in the treatment of refractory congestive heart failure.
Cotter G; Weissgarten J; Metzkor E; Moshkovitz Y; Litinski I; Tavori U; Perry C; Zaidenstein R; Golik A
Clin Pharmacol Ther; 1997 Aug; 62(2):187-93. PubMed ID: 9284855
[TBL] [Abstract][Full Text] [Related]
12. Furosemide absorption in patients with cirrhosis.
Fredrick MJ; Pound DC; Hall SD; Brater DC
Clin Pharmacol Ther; 1991 Mar; 49(3):241-7. PubMed ID: 2007318
[TBL] [Abstract][Full Text] [Related]
13. High-dose furosemide in the treatment of refractory congestive heart failure.
Gerlag PG; van Meijel JJ
Arch Intern Med; 1988 Feb; 148(2):286-91. PubMed ID: 3341836
[TBL] [Abstract][Full Text] [Related]
14. [Body fluid withdrawal with isolated ultrafiltration effects persistent improvement of functional capacity in patients with chronic congestive heart failure. Furosemide does not produce the same result].
Marenzi G; Guazzi M; Lauri G; Perego GB; Sganzerla P; Agostoni P
Cardiologia; 1994 Nov; 39(11):763-72. PubMed ID: 7736475
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics and pharmacodynamics of furosemide after direct administration into the stomach or duodenum.
Lee WI; Yoon WH; Shin WG; Song IS; Lee MG
Biopharm Drug Dispos; 1997 Dec; 18(9):753-67. PubMed ID: 9429740
[TBL] [Abstract][Full Text] [Related]
16. Population-based meta-analysis of furosemide pharmacokinetics.
Van Wart SA; Shoaf SE; Mallikaarjun S; Mager DE
Biopharm Drug Dispos; 2014 Mar; 35(2):119-33. PubMed ID: 24151207
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of digoxin administered to horses with congestive heart failure.
Sweeney RW; Reef VB; Reimer JM
Am J Vet Res; 1993 Jul; 54(7):1108-11. PubMed ID: 8368606
[TBL] [Abstract][Full Text] [Related]
18. The effects of diuresis on the pharmacokinetics of the loop diuretics furosemide and torsemide in patients with heart failure.
Gottlieb SS; Khatta M; Wentworth D; Roffman D; Fisher ML; Kramer WG
Am J Med; 1998 Jun; 104(6):533-8. PubMed ID: 9674715
[TBL] [Abstract][Full Text] [Related]
19. Lowering of furosemide dosage after clinical stabilization in patients with congestive heart failure.
Alexopoulos GP; Anastasiou-Nana MI; Rapti ACh; Margari ZJ; Terrovitis JV; Mitsibounas D; Makri S; Nanas JN
Acta Cardiol; 2003 Dec; 58(6):513-7. PubMed ID: 14713176
[TBL] [Abstract][Full Text] [Related]
20. Six-week study of torsemide in patients with congestive heart failure.
Goebel KM
Clin Ther; 1993; 15(6):1051-9. PubMed ID: 8111802
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
